Gianmarco Contino is an Associate Professor of Cancer Genomic Medicine and Group Leader at the Institute of Cancer and Genetic Sciences at the University of Birmingham Medical School. He serves as an Upper GI consultant at Queen Elizabeth Hospital, part of the University Hospitals Birmingham NHS Trust. He is also a Research Fellow at the Von Hügel Institute for Advanced Studies at the University of Cambridge. Additionally, he is the Director of the MSc in Clinical Oncology at the University of Birmingham and the Network Chair of the EORTC Pathobiology Group. Previously, he was a clinical lecturer at the University of Cambridge and Addenbrooke’s Hospital. He trained as a surgical oncologist and translational scientist at the European Institute of Oncology (Milan), Harvard Medical School, Massachusetts General Hospital (Boston), the University of Illinois at Chicago, and Imperial College London. Gianmarco's research focuses on upper gastrointestinal cancers. As part of the International Cancer Genome Consortium, he worked on identifying structural variations that drive oesophageal adenocarcinoma. He is currently investigating functional genomics to understand the molecular mechanisms behind chromosomal instability in oesophageal adenocarcinoma. His clinical work includes advanced endoscopy and endoscopic treatment of upper gastrointestinal cancers. He has published extensively on the genomics and molecular therapeutics of pancreatic and oesophageal adenocarcinoma in journals like Science and Nature. Gianmarco is committed to training the next generation of clinician scientists and volunteers for organizations helping students from disadvantaged backgrounds to get into STEM.